Leptin has been reported to reduce hyperglycaemia in rodent models of type 1 diabetes and has recently been shown to normalise fasting plasma glucose concentrations in a rodent model of polygenic obesity and type 2 diabetes [14]. The gene discussed is LEP; the disease is type 1 diabetes mellitus.